AR032876A1 - CARBAMATE COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF PSYCHOTIC DISORDERS - Google Patents
CARBAMATE COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF PSYCHOTIC DISORDERSInfo
- Publication number
- AR032876A1 AR032876A1 ARP020100702A ARP020100702A AR032876A1 AR 032876 A1 AR032876 A1 AR 032876A1 AR P020100702 A ARP020100702 A AR P020100702A AR P020100702 A ARP020100702 A AR P020100702A AR 032876 A1 AR032876 A1 AR 032876A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- psychotic disorders
- phenyl
- alkyl
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Abstract
La presente hace referencia a un método para prevenir o tratar trastornos psicoticos que comprende la administracion a un paciente que lo necesita de una cantidad terapéuticamente eficaz de un compuesto seleccionado del grupo formado por las formulas (1) y (2). Donde fenilo se sustituye en X con uno a cinco átomos de halogeno seleccionados del grupo compuesto por fluor, bromo, y yodo; R1, R2, R3, R4, R5 y R6 son independientemente seleccionados del grupo compuesto por hidrogeno y alquilo de C1-4; donde el alquilo de C1-4 es opcionalmente sustituido con fenilo (en el cual el fenilo es opcionalmente sustituido con sustituyentes independientemente seleccionado del grupo compuesto por halogeno, alquilo de C1-4, alcoxi de C1-4, amino, nitro y ciano).This refers to a method to prevent or treat psychotic disorders that comprises administering to a patient in need of a therapeutically effective amount of a compound selected from the group consisting of formulas (1) and (2). Where phenyl is substituted at X with one to five halogen atoms selected from the group consisting of fluorine, bromine, and iodine; R1, R2, R3, R4, R5 and R6 are independently selected from the group consisting of hydrogen and C1-4 alkyl; wherein the C1-4 alkyl is optionally substituted with phenyl (in which the phenyl is optionally substituted with substituents independently selected from the group consisting of halogen, C1-4 alkyl, C1-4 alkoxy, amino, nitro and cyano).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27188901P | 2001-02-27 | 2001-02-27 | |
| US10/081,761 US6541513B2 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating psychotic disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR032876A1 true AR032876A1 (en) | 2003-11-26 |
Family
ID=26765939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020100702A AR032876A1 (en) | 2001-02-27 | 2002-02-27 | CARBAMATE COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF PSYCHOTIC DISORDERS |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6541513B2 (en) |
| EP (1) | EP1401424B1 (en) |
| JP (1) | JP4276841B2 (en) |
| KR (1) | KR100886578B1 (en) |
| CN (1) | CN1262271C (en) |
| AR (1) | AR032876A1 (en) |
| AT (1) | ATE346597T1 (en) |
| AU (1) | AU2002242296B2 (en) |
| BR (1) | BR0207829A (en) |
| CA (1) | CA2439480C (en) |
| CZ (1) | CZ302412B6 (en) |
| DE (1) | DE60216457T2 (en) |
| DK (1) | DK1401424T3 (en) |
| ES (1) | ES2275844T3 (en) |
| HU (1) | HUP0303342A3 (en) |
| IL (2) | IL157588A0 (en) |
| MX (1) | MXPA03007722A (en) |
| NO (1) | NO20033801L (en) |
| NZ (1) | NZ527991A (en) |
| PL (1) | PL365021A1 (en) |
| PT (1) | PT1401424E (en) |
| RS (1) | RS51056B (en) |
| RU (1) | RU2302240C2 (en) |
| TW (1) | TWI251486B (en) |
| WO (1) | WO2002067927A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1305082E (en) * | 2000-07-21 | 2004-09-30 | Ortho Mcneil Pharm Inc | CARBAMATE COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF NEUROPATHIC PAIN AND PAIN ASSOCIATED WITH SAFEGUARD OF SALVAS AND ENXAQUECA |
| EP1399144B1 (en) | 2001-02-27 | 2006-04-26 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating anxiety disorders |
| DE60220043T2 (en) * | 2001-02-27 | 2008-01-10 | Ortho-Mcneil Pharmaceutical, Inc. | CARBAMATE COMPOUNDS FOR PREVENTING OR TREATING NEURODEEGENERATIVE DISORDER |
| RS50948B (en) | 2001-07-16 | 2010-08-31 | Ortho-Mcneil Pharmaceutical Inc. | Carbamate compounds for use in preventing or treating neuropathic pain |
| WO2005107719A2 (en) * | 2004-05-06 | 2005-11-17 | Sandoz Ag | Pharmaceutical composition comprising hydrophobic drug having improved solubility |
| EP1928451B1 (en) * | 2005-07-26 | 2011-12-28 | SK Biopharmaceuticals Co., LTD | Methods for treating substance-related disorders |
| EP2081648A2 (en) * | 2006-10-30 | 2009-07-29 | Janssen Pharmaceutica, N.V. | Carbamate compounds for use in treating depression |
| EP2089011A1 (en) * | 2006-10-31 | 2009-08-19 | Janssen Pharmaceutica N.V. | Treatment of pervasive developmental disorders |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| CN109939092B (en) | 2013-03-12 | 2022-03-22 | 比皮艾思药物研发有限公司 | Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndrome |
| KR102014615B1 (en) * | 2013-03-12 | 2019-08-27 | (주)바이오팜솔루션즈 | Phenyl carbamate compound and a composition for neuroprotection comprising the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| US5492930A (en) * | 1994-04-25 | 1996-02-20 | Schering Corporation | Method and formulation for treating CNS disorders |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
-
2002
- 2002-02-21 NZ NZ527991A patent/NZ527991A/en unknown
- 2002-02-21 PT PT02707927T patent/PT1401424E/en unknown
- 2002-02-21 RU RU2003128983/14A patent/RU2302240C2/en active
- 2002-02-21 EP EP02707927A patent/EP1401424B1/en not_active Expired - Lifetime
- 2002-02-21 CZ CZ20032297A patent/CZ302412B6/en not_active IP Right Cessation
- 2002-02-21 DK DK02707927T patent/DK1401424T3/en active
- 2002-02-21 PL PL02365021A patent/PL365021A1/en unknown
- 2002-02-21 US US10/081,761 patent/US6541513B2/en not_active Expired - Lifetime
- 2002-02-21 BR BR0207829-5A patent/BR0207829A/en not_active Application Discontinuation
- 2002-02-21 DE DE60216457T patent/DE60216457T2/en not_active Expired - Lifetime
- 2002-02-21 ES ES02707927T patent/ES2275844T3/en not_active Expired - Lifetime
- 2002-02-21 AU AU2002242296A patent/AU2002242296B2/en not_active Ceased
- 2002-02-21 AT AT02707927T patent/ATE346597T1/en active
- 2002-02-21 RS YUP-675/03A patent/RS51056B/en unknown
- 2002-02-21 CA CA2439480A patent/CA2439480C/en not_active Expired - Fee Related
- 2002-02-21 CN CNB028089235A patent/CN1262271C/en not_active Expired - Fee Related
- 2002-02-21 MX MXPA03007722A patent/MXPA03007722A/en active IP Right Grant
- 2002-02-21 KR KR1020037011292A patent/KR100886578B1/en active IP Right Grant
- 2002-02-21 JP JP2002567294A patent/JP4276841B2/en not_active Expired - Lifetime
- 2002-02-21 WO PCT/US2002/006119 patent/WO2002067927A1/en active IP Right Grant
- 2002-02-21 IL IL15758802A patent/IL157588A0/en unknown
- 2002-02-21 HU HU0303342A patent/HUP0303342A3/en unknown
- 2002-02-27 AR ARP020100702A patent/AR032876A1/en unknown
- 2002-03-05 TW TW091103972A patent/TWI251486B/en not_active IP Right Cessation
-
2003
- 2003-08-26 NO NO20033801A patent/NO20033801L/en not_active Application Discontinuation
- 2003-08-26 IL IL157588A patent/IL157588A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR033426A1 (en) | USE OF CARBAMATE COMPOUNDS IN THE PREVENTION OR TREATMENT OF MOVEMENT DISORDERS | |
| AR054524A1 (en) | METHODS AND DOSAGE FORMS TO REDUCE THE SIDE EFFECTS OF CARBAMATE COMPOUNDS | |
| ECSP088179A (en) | CARBAMATE COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| EA200800422A1 (en) | METHODS OF TREATMENT OF DISEASES DETERMINED BY CHEMICALS | |
| AR035756A1 (en) | USE OF CARBAMATES IN THE PREPARATION OF MEDICINES FOR THE PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISORDERS | |
| AR032876A1 (en) | CARBAMATE COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF PSYCHOTIC DISORDERS | |
| AR033427A1 (en) | USE OF CARBAMATE COMPOUNDS IN PAIN TREATMENT | |
| ECSP088172A (en) | METHODS TO TREAT EPILEPTOGENESIS | |
| DK1408953T3 (en) | Carbamate compounds for use in the prevention or treatment of bipolar disorder | |
| DE60223506D1 (en) | CARBAMATE COMPOUNDS FOR PREVENTING OR TREATING BIPOLAR DISEASES | |
| DE60210960D1 (en) | CARBAMATE COMPOUNDS FOR THE PREVENTION OR TREATMENT OF DIFFICULTIES | |
| CO6160292A2 (en) | METHODS OF TREATMENT OF DISTURBING BEHAVIOR DISORDERS 877 | |
| AR032907A1 (en) | USE OF CARBAMATE COMPOUNDS FOR THE PREVENTION OR TREATMENT OF ANXIETY DISORDERS | |
| AR033428A1 (en) | CARBAMATE COMPOUNDS FOR USE IN THE PREVENTION OR TREATMENT OF BIPOLAR DISORDERS | |
| BR0211240A (en) | Carbamate compounds for use in the prevention or treatment of neuropathic pain and cluster and hemicranial headache pain | |
| AR035757A1 (en) | USE OF CARBAMATES FOR THE MANUFACTURE OF MEDICINES TO PREVENT OR TREAT A BIPOLAR DISORDER | |
| CR9766A (en) | METHODS FOR THE TREATMENT OF SUBSTANCE-RELATED DISORDERS | |
| AR034785A1 (en) | CARBAMATE COMPOUNDS TO BE USED IN THE PREVENTION OR TREATMENT OF NEUROPATHIC PAIN AND PAIN ASSOCIATED WITH MIGRANEOUS HEAD AND ACCUMINATED HEAD | |
| MY136733A (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| AR034786A1 (en) | CARBAMATE COMPOUNDS TO BE USED IN THE PREVENTION OR TREATMENT OF NEUROPATHIC PAIN AND PAIN ASSOCIATED WITH MIGRANEOUS HEAD AND ACCUMINATED HEAD | |
| MY149385A (en) | Methods for treating substance-related disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |